Skip to content
Politically.com Search all
Menu

2025 · 1st Quarter (Jan 1 - Mar 31)

ALLIANCE FOR PHARMACY COMPOUNDING

Filed by HANCE SCARBOROUGH.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 17, 2025
Income
$50,000.00
Expenses
Not reported
Filing UUID
075918b8-436e-445d-976b-db3c78835d08
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations. HR167, the Patient Access to Urgent Use Compounded Medication Act

Literal federal measure citations: HR167

PHA · Pharmacy

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations. HR167, the Patient Access to Urgent Use Compounded Medication Act

Literal federal measure citations: HR167

BUD · Budget/Appropriations

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations. HR167, the Patient Access to Urgent Use Compounded Medication Act

Literal federal measure citations: HR167

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.